Extraction form for project: IPMP (Integrated Pain Management Programs)

Design Details

1. What type of program does the study assess (IPMP or CPMP)?
Integrated Pain Management Program (IPMP): Based in, integrated with, coordinated by primary care. Comprehensive Pain Management Program (CPMP): Referral based and separate from primary care.
2. In what country was the study conducted?
List all applicable countries.
3. What study design was used?
Please select the appropriate study design for the study. If the study design is not listed, you may add the appropriate study design.
4. Mean age
Report across all patients included in relevant study arms. Round to whole number. Include the word "years" after reporting the mean age.
5. % male
Report across all patients included in relevant study arms. Round to whole number. Include "%" symbol.
6. % Non-white
Report across all patients included in relevant study arms. Round to whole number. Include "%" symbol. If not reported, put NR.
7. Mean duration of pain or symptoms
Report across all patients included in relevant study arms. Round to whole number. Report duration in terms of months. If not reported, put NR.
8. Pain etiology/type
9. Disability
Disability can be measured in several ways. For example, authors may report the percent of patients receiving disability payments or they may report the mean score of a continuous disability scale such as the Pain Disability Index. Either are appropriate here, just be explicit about what is being reported.
10. Comorbidities
Extract the percent of patients with relevant comorbidities. Round percentages to whole numbers. If not reported, put NR.
% Depression diagnosis
% Anxiety diagnosis
% PTSD disagnosis
% Overweight or obese
% w/ Substance Use Disorder
% Smokers
% Suicidal
11. Randomized, Analyzed, and Attrition (at longest followup point)
For attrition report as: % (n/N)
Randomized
Analyzed
Attrition
12. How was the study funded?
13. Notes and comments

Arms

Arm NameArm Description
CPMPComprehensive
Conventional pharmacological therapy

Arm Details

1. Is the program practice-based or system-based?
CPMP
Conventional pharmacological therapy
2. How many patients were randomized to this treatment arm?
CPMP
Conventional pharmacological therapy
3. Program duration (weeks)
Please report the duration of the program in weeks and include "weeks" in the text box.
CPMP
Conventional pharmacological therapy
4. Number of sessions per week
Report as X sessions/week
CPMP
Conventional pharmacological therapy
5. Was the program conducted in the inpatient or outpatient setting?
Select one.
CPMP
Conventional pharmacological therapy
6. Physical Functioning/Reconditioning & Psychological and Mental Health Components of Intervention
For treatment providers, you may write-in any options that are needed that are not already presented. For duration of treatment report as "X sessions per week over X weeks", when possible. For anything not reported, put NR.
CPMP
Physical Functioning/Reconditioning Components of InterventionPsychological and Mental Health Components of Intervention
Treatment types
Treatment providers
Mode of delivery
Duration of treatment
Tailoring
Adherence
Conventional pharmacological therapy
Physical Functioning/Reconditioning Components of InterventionPsychological and Mental Health Components of Intervention
Treatment types
Treatment providers
Mode of delivery
Duration of treatment
Tailoring
Adherence
7. Medication Review and/or Management Components of Intervention
CPMP
Conventional pharmacological therapy
8. Additional components of the intervention
CPMP
Conventional pharmacological therapy
9. Description of care coordination/collaboration
CPMP
Conventional pharmacological therapy

Sample Characteristics

N/A

Outcomes

TypeDomainSpecific measurement (i.e., tool/definition/specific outcome)PopulationsTimepoints
ContinuousPainPain NRS
  • all patients
  • Normal weight
  • Overweight
  • Obese
  • Baseline
  • post treatment
  • 3 months
  • 6 months
  • 12 months
ContinuousPsychological distress HADS
  • all patients
  • Normal weight
  • Overweight
  • Obese
  • Baseline
  • Posttreatment
  • 3 months
  • 6 months
  • 12 months
CategoricalHarms Adverse events
  • All Participants
  • Baseline
CategoricalFunctionProportion of patients meeting the MCID of 30% improvement on the NRS
  • All Participants
  • post treatment
  • 3 months
  • 6 months
  • 12 months
ContinuousFunctionFIQ - All patients
  • All Participants
  • Baseline
  • post treatment
  • 3 months
  • 6 months
  • 12 months
ContinuousPsychological MeasuresCoping Strategies Questionnaire catastrophizing subscale
  • All Participants
  • All patients
  • Normal weight (BMI < 25 kg/m^2)
  • Overweight (BMI 25.0 to 29.9 kg/m^2)
  • post treatment
  • 3 months
  • 6 months
  • 12 months

Outcome Details

N/A

Risk of Bias Assessment

1. Randomization adequate?
Rating
2. Allocation concealment adequate?
Rating
3. Groups similar at baseline?
Rating
4. Outcome assessors masked?
Rating
5. Care providers masked?
Rating
6. Patient masked?
Rating
7. Reporting of attrition, crossovers, adherence, and contamination?
Rating
8. Loss to followup acceptable?
Overall ≤20%?
Difference between groups <10%?
9. Intention-to-treat (ITT) analysis?
Overall ≤20%?
10. Outcomes prespecified?
Overall ≤20%?
11. Quality determination
Overall ≤20%?

Results

Categorical


Harms ( Adverse events)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy

Function (Proportion of patients meeting the MCID of 30% improvement on the NRS)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
post treatment
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
p value
3 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
p value
6 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
p value
12 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy

Continuous


Pain (Pain NRS)

all patients
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
post treatment
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
3 months
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
6 months
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
12 months
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy
Normal weight
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
post treatment
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
3 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
6 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
12 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy
Overweight
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
post treatment
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
3 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
6 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
12 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy
Obese
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
post treatment
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
3 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
6 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
12 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy

Psychological distress (HADS)

all patients
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
Posttreatment
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
3 months
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
6 months
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
12 months
Total (N analyzed)
Odds Ratio (OR)
Mean
95% CI low (OR)
SD
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy
Normal weight
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
Posttreatment
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
3 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
6 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
12 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy
Overweight
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
Posttreatment
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
3 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
6 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
12 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy
Obese
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
Posttreatment
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
3 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
6 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
12 months
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
Mean
p value
SD
95% CI high
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy

Function (FIQ - All patients)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
Baseline
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD (MD)
p value (MD)
Odds Ratio (OR)
95% CI low (OR)
95% CI high (OR)
p value
post treatment
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD (MD)
p value (MD)
Odds Ratio (OR)
95% CI low (OR)
95% CI high (OR)
p value
3 months
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD (MD)
p value (MD)
Odds Ratio (OR)
95% CI low (OR)
95% CI high (OR)
p value
6 months
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD (MD)
p value (MD)
Odds Ratio (OR)
95% CI low (OR)
95% CI high (OR)
p value
12 months
Total (N analyzed)
Mean Difference (MD)
Mean
95% CI low (MD)
SD
95% CI high (MD)
SD (MD)
p value (MD)
Odds Ratio (OR)
95% CI low (OR)
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy

Psychological Measures (Coping Strategies Questionnaire catastrophizing subscale)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
post treatment
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
3 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
6 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
12 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy
All patients
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
post treatment
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
3 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
6 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
12 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy
Normal weight (BMI < 25 kg/m^2)
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
post treatment
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
3 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
6 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
12 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy
Overweight (BMI 25.0 to 29.9 kg/m^2)
Descriptive StatisticsBetween Arm Comparisons
CPMP Conventional pharmacological therapy
post treatment
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
3 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
6 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
12 months
Total (N analyzed)
Mean Difference (MD)
Events
95% CI low (MD)
Percentage
95% CI high (MD)
Mean
SD (MD)
SD
p value (MD)
SD
Odds Ratio (OR)
95% CI high
95% CI low (OR)
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP Conventional pharmacological therapy